John Wiley & Sons-A
WLY
48.80
+0.35
+0.72%
John Wiley & Sons-A
US · WLY
#2642 by market cap
Listed 1970
48.80
+0.35
+0.72%
Live - 5344 symbols - heartbeat 63s ago
· 2026-10-08 05:01
Pre-market
48.42
-0.78%
After-hours
48.80
0.00%
- Market cap
- 2.47B
- P/E (TTM)i
- 13.15
- P/Bi
- 3.10
- EPSi
- 4.16
- Div yieldi
- 2.92%
- 52W posi
- 72%
Reader sentiment
Are you bullish or bearish on WLY?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.65, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -0.06% YoY
Margins
- Gross margin
- 74.26%
- Operating margin
- 17.66%
- Net margin
- 13.22%
Key ratios & quality
- Enterprise valuei
- 3.10B
- PEG ratioi
- 0.10
- Altman Z-Scorei
- 2.65
PEG uses trailing P/E against the 3-year net income growth rate (134.29%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.80B | 1.83B | 1.94B | 2.08B | 2.02B | 1.87B | 1.68B | 1.68B |
| Gross profit | 1.25B | 1.24B | 1.32B | 1.38B | 1.33B | 1.29B | 1.25B | 1.25B |
| Selling & admin expenses | -- | -- | -- | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 227.11M | 180.67M | 218.82M | 217.85M | 205.08M | 223.75M | 246.97M | 296.06M |
| Pretax profit | 212.95M | -63.09M | 175.91M | 209.66M | 33.10M | -187.05M | 142.88M | 215.09M |
| Tax | 44.69M | 11.20M | 27.66M | 61.35M | 15.87M | 13.27M | 58.72M | -6.53M |
| Net profit | 168.26M | -74.29M | 148.26M | 148.31M | 17.23M | -200.32M | 84.16M | 221.62M |
| Basic EPS | 3 | -1 | 3 | 3 | 0 | -4 | 2 | 4 |
| Diluted EPS | 2.91 | -1.32 | 2.63 | 2.62 | 0.31 | -3.65 | 1.53 | 4.16 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 442.58M | 396.80M | 421.75M | 410.04M | 447.94M | 386.36M |
| Gross profit | 331.64M | 287.54M | 317.36M | 302.26M | 337.86M | 285.49M |
| Selling & admin expenses | -- | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 88.96M | 34.00M | 79.03M | 69.82M | 113.22M | 30.50M |
| Pretax profit | 52.27M | 17.71M | 58.01M | 44.40M | 94.97M | -12.58M |
| Tax | -15.83M | 6.01M | 13.12M | 14.72M | -40.37M | -850.00K |
| Net profit | 68.09M | 11.70M | 44.89M | 29.68M | 135.35M | -11.73M |
| Basic EPS | 1 | 0 | 1 | 1 | 3 | 0 |
| Diluted EPS | 1.25 | 0.22 | 0.84 | 0.56 | 2.61 | -0.23 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 502.54M | 614.93M | 526.30M | 550.87M | 541.28M | 454.04M | 439.88M | 419.67M |
| Cash & ST investments | 92.89M | 202.46M | 93.80M | 100.40M | 106.71M | 83.25M | 85.88M | 75.62M |
| Inventory | 35.58M | 43.61M | 42.54M | 36.59M | 30.73M | 26.22M | 22.88M | 19.27M |
| Total assets | 2.95B | 3.17B | 3.45B | 3.36B | 3.11B | 2.73B | 2.69B | 2.59B |
| Total current liabilities | 882.33M | 927.27M | 988.97M | 969.42M | 895.55M | 873.28M | 820.86M | 778.95M |
| Short-term debt | -- | 31.19M | 34.94M | 39.33M | 24.67M | 25.79M | 28.28M | 28.45M |
| Long-term debt | 478.79M | 765.65M | 809.09M | 768.28M | 743.29M | 767.10M | 789.44M | 670.90M |
| Total liabilities | 1,767,419,000.00 | 2,235,170,000.00 | 2,355,148,000.00 | 2,219,426,000.00 | 2,063,783,000.00 | 1,985,779,000.00 | 1,939,260,000.00 | 1,743,576,000.00 |
| Total equity | 1.18B | 933.62M | 1.09B | 1.14B | 1.05B | 739.72M | 752.21M | 848.24M |
| Retained earnings | 1.93B | 1.78B | 1.85B | 1.92B | 1.86B | 1.58B | 1.59B | 1.74B |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 439.88M | 420.30M | 381.22M | 411.25M | 419.67M | 438.22M |
| Cash & ST investments | 85.88M | 81.85M | 67.40M | 95.12M | 75.62M | 106.43M |
| Inventory | 22.88M | 21.95M | 21.39M | 19.30M | 19.27M | 18.47M |
| Total assets | 2.69B | 2.52B | 2.47B | 2.56B | 2.59B | 3.13B |
| Total current liabilities | 820.86M | 648.84M | 540.35M | 692.42M | 778.95M | 688.82M |
| Short-term debt | 28.28M | 27.51M | 26.64M | 27.49M | 28.45M | 29.86M |
| Long-term debt | 789.44M | 818.27M | 861.71M | 796.29M | 670.90M | 1.28B |
| Total liabilities | 1,939,260,000.00 | 1,791,273,000.00 | 1,726,550,000.00 | 1,811,353,000.00 | 1,743,576,000.00 | 2,335,360,000.00 |
| Total equity | 752.21M | 733.06M | 740.19M | 749.98M | 848.24M | 797.04M |
| Retained earnings | 1.59B | 1.58B | 1.61B | 1.62B | 1.74B | 1.71B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 250.83M | 288.44M | 359.92M | 339.10M | 277.07M | 207.64M | 202.59M | 260.52M |
| Depreciation & amortization | 161.16M | 175.13M | 200.19M | 215.17M | 214.06M | 178.20M | 148.21M | 146.25M |
| Free cash flow | 139.74M | 171.39M | 226.71M | 217.40M | 170.38M | 105.88M | 119.82M | 176.67M |
| Dividends paid | -75.75M | -76.66M | -76.94M | -77.21M | -77.30M | -76.96M | -76.10M | -74.36M |
| Stock buybacks / issuance | -59.99M | -46.59M | -15.77M | -30.00M | -35.00M | -45.05M | -60.42M | -100.08M |
| Ending cash balance | 93.55M | 203.05M | 94.36M | 100.73M | 107.26M | 99.54M | 85.93M | 75.67M |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | 150.34M | -85.01M | 8.50M | 179.82M | 157.21M | -55.27M |
| Depreciation & amortization | 37.76M | 36.45M | 35.93M | 35.59M | 38.28M | 37.32M |
| Free cash flow | 125.11M | -101.32M | -16.88M | 152.99M | 141.88M | -70.27M |
| Dividends paid | -18.86M | -18.99M | -18.79M | -18.53M | -18.06M | -18.17M |
| Stock buybacks / issuance | -25.00M | -13.50M | -21.59M | -34.88M | -30.12M | -15.23M |
| Ending cash balance | 85.93M | 81.90M | 67.45M | 95.17M | 75.67M | 106.48M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 14.19 | -7.02 | 14.64 | 13.28 | 1.58 | -22.45 | 11.28 | 27.69 |
| ROA %i | 5.83 | -2.43 | 4.48 | 4.36 | 0.53 | -6.87 | 3.11 | 8.39 |
| ROIC %i | 10.73 | -3.68 | 8.25 | 7.80 | 2.26 | -9.22 | 7.52 | 15.17 |
| 5-year avg ROE %i | 14.52 | 9.95 | 10.09 | 10.52 | 7.33 | 0.01 | 3.67 | 6.28 |
| EBIT margin %i | 12.73 | -2.08 | 10.01 | 11.02 | 3.51 | -7.37 | 11.65 | 15.44 |
| FCF / sales %i | 9.12 | 10.81 | 11.68 | 10.44 | 8.44 | 5.65 | 7.14 | 10.54 |
| Current ratioi | 0.57 | 0.66 | 0.53 | 0.57 | 0.60 | 0.52 | 0.54 | 0.54 |
| Quick ratioi | 0.45 | 0.55 | 0.41 | 0.45 | 0.47 | 0.35 | 0.38 | 0.41 |
| Debt / assetsi | 16.24 | 30.19 | 28.72 | 27.97 | 28.42 | 32.55 | 33.41 | 29.67 |
| LT debt / equityi | 40.53 | 99.12 | 87.50 | 78.86 | 82.18 | 116.46 | 115.78 | 87.29 |
| Interest coveragei | 14.21 | -1.53 | 10.57 | 11.59 | 1.88 | -2.82 | 3.72 | 5.91 |
| Revenue CAGR (3Y) %i | 1.39 | 2.14 | 2.63 | 4.99 | 3.32 | -1.19 | -6.96 | -6.02 |
| Net income CAGR (3Y) %i | 4.90 | -- | -8.29 | -4.12 | -- | -- | -17.21 | 134.29 |
| FCF CAGR (3Y) %i | -16.86 | -1.80 | -2.07 | 15.87 | -0.20 | -22.41 | -18.01 | 1.22 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | 11.28 | 13.45 | 13.61 | 21.51 | 27.69 | 25.91 |
| ROA %i | 3.11 | 3.76 | 4.01 | 5.98 | 8.39 | 7.01 |
| ROIC %i | 7.52 | 7.84 | 7.66 | 11.75 | 15.17 | 11.82 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 11.65 | 11.28 | 11.69 | 13.04 | 15.44 | 13.90 |
| FCF / sales %i | 7.14 | 7.49 | 7.91 | 9.57 | 10.54 | 12.47 |
| Current ratioi | 0.54 | 0.65 | 0.71 | 0.59 | 0.54 | 0.64 |
| Quick ratioi | 0.38 | 0.47 | 0.51 | 0.43 | 0.41 | 0.46 |
| Debt / assetsi | 33.41 | 36.60 | 39.11 | 35.04 | 29.67 | 43.89 |
| LT debt / equityi | 115.78 | 122.29 | 126.72 | 115.99 | 87.29 | 168.75 |
| Interest coveragei | 3.72 | 3.71 | 4.05 | 4.79 | 5.91 | 4.95 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Research is the largest reported line at 75.96% of revenue, across 2 reported segments.
- The next-largest line, Learning, is a distant second at 24.04% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Research75.96%
Learning24.04%
Quote time 2026-10-08 05:01:03 · For reference only, not investment advice and not tailored to your situation.